Biohaven Ltd. short interest in 2023
In 2023, Biohaven Ltd.'s disclosed short interest ran from 6.79% of shares outstanding on 13 Jan 2023 to 9.33% on 29 Dec 2023, a change of +2.54 percentage points. The year's high was 10.68% on 15 Jun 2023 and its low 4.84% on 15 Feb 2023, averaging 8.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.22 days on 15 May 2023. Full history: Biohaven Ltd..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 6.79% (13 Jan 2023)
- End of year
- 9.33% (29 Dec 2023)
- Change
- +2.54 pp
- High
- 10.68% (15 Jun 2023)
- Low
- 4.84% (15 Feb 2023)
- Average
- 8.50%
- Highest days to cover
- 11.22 (15 May 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 6.79% | 3.61 | |
| 31 Jan 2023 | 4.98% | 3.91 | |
| 15 Feb 2023 | 4.84% | 4.04 | |
| 28 Feb 2023 | 9.39% | 6.41 | |
| 15 Mar 2023 | 8.71% | 5.03 | |
| 31 Mar 2023 | 10.34% | 7.51 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 9.77% | 7.57 | |
| 28 Apr 2023 | 10.27% | 10.38 | |
| 15 May 2023 | 10.07% | 11.22 | 10-Q filed, results (8-K) |
| 31 May 2023 | 8.88% | 5.19 | |
| 15 Jun 2023 | 10.68% | 4.84 | |
| 30 Jun 2023 | 8.53% | 4.16 | |
| 14 Jul 2023 | 6.92% | 7.37 | |
| 31 Jul 2023 | 7.17% | 3.21 | 10-Q filed, results (8-K) |
| 15 Aug 2023 | 8.09% | 8.21 | |
| 31 Aug 2023 | 7.68% | 8.47 | |
| 15 Sep 2023 | 7.63% | 5.38 | |
| 29 Sep 2023 | 10.42% | 4.49 | |
| 13 Oct 2023 | 9.72% | 4.29 | |
| 31 Oct 2023 | 9.83% | 6.43 | |
| 15 Nov 2023 | 7.70% | 5.35 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 8.20% | 5.98 | |
| 15 Dec 2023 | 8.17% | 4.98 | |
| 29 Dec 2023 | 9.33% | 5.90 |
See also: Biohaven Ltd.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.